Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Varga, GergelyNagy, ZsoltDemeter, JuditKosztolányi, SzabolcsSzomor, ÁrpádAlizadeh, HussainDeák, BeátaSchneider, TamásPlander, MárkSzendrei, TamásVáróczy, LászlóIllés, ÁrpádBátai, ÁrpádPető, MónikaMikala, Gábor2019-02-042019-02-042019Pathology & Oncology Research. -25 : 4 (2019), p. 1615-1620. -Pathol. Oncol. Res. - 1219-4956. - 1532-28071219-49561532-2807http://hdl.handle.net/2437/263563Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Programfolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM076936OrvostudományokKlinikai orvostudományokhttp://link.springer.com/10.1007/s12253-019-00607-2http://dx.doi.org/10.1007/s12253-019-00607-22019-12-0500049266310003885061044371